Cat. No. 5189
Chemical Name: 3-[[3-[(Cyclopropylamino)sulfonyl]-
Biological ActivityPotent, selective lactate dehydrogenase A (LDHA) inhibitor (IC50 values are 1.9 and 14 nM for LDHA and LDHB respectively). Inhibits lactate production in selected cancer cell lines. Reduces glucose uptake and enhances mitochondrial oxygen consumption in Snu398 hepatocellular carcinoma cells. Inhibits proliferation and induces apoptosis in Snu398 cells. Cell permeable.
Licensing InformationSold for research purposes under agreement from GlaxoSmithKline.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Xie et al (2014) Targeting lactate dehydrogenase-A inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells. Cell.Metab. 19 795. PMID: 24726384.
Billiard et al (2013) Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells. Cancer Metab. 1 19. PMID: 24280423.
If you know of a relevant reference for GSK 2837808A please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses GSK 2837808A from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: GSK 2837808A, supplier, GSK2837808A, potent, selective, lactate, dehydrogenase, A, LDHA, inhibitors, inhibits, Tocris Bioscience, Lactate Dehydrogenase A Inhibitor products
Find multiple products by catalog number
New Products in this Area
Potent and selective ALDH1A1 inhibitor
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.